A 52-year-old man from Mumbai presents with a 3-month history of progressive abdominal distension, early satiety, and weight loss of 8 kg. On examination, he has hepatomegaly (4 cm below costal margin) and ascites. Ultrasound abdomen shows a 6 cm heterogeneous mass in the right lobe of liver with features suggestive of hepatocellular carcinoma. Serum alpha-fetoprotein (AFP) level is 1200 ng/mL (normal <20 ng/mL). CT abdomen confirms a solitary HCC without extrahepatic metastases. The patient is being considered for surgical resection. Which of the following best explains the prognostic significance of the elevated AFP in this case?

Explanation

## Prognostic Role of AFP in Hepatocellular Carcinoma ### Clinical Context Alpha-fetoprotein (AFP) is the most widely used tumor marker for HCC diagnosis and prognostication. In this case, the markedly elevated AFP (1200 ng/mL) in the setting of imaging-confirmed HCC provides critical prognostic information. ### Prognostic Significance of AFP Levels **Key Point:** AFP level at diagnosis is an independent predictor of recurrence-free survival (RFS) and overall survival (OS) after curative treatment (resection, transplantation, or ablation). | AFP Level | Prognostic Implication | 5-Year RFS | Clinical Significance | |-----------|------------------------|-----------|----------------------| | <20 ng/mL | Normal, very low risk | ~70% | Excellent prognosis | | 20–400 ng/mL | Intermediate risk | ~50–60% | Moderate prognosis | | >400 ng/mL | High risk | ~30–40% | Poor prognosis, higher recurrence | | >1000 ng/mL | Very high risk | <30% | Aggressive biology, rapid recurrence | **High-Yield:** AFP >400 ng/mL is associated with: - Higher rates of microvascular invasion - Increased likelihood of intrahepatic metastases - Shorter time to recurrence after resection - Worse overall survival However, elevated AFP does NOT preclude surgical resection if the patient meets other criteria (adequate liver function, no extrahepatic disease, resectable tumor). ### Role of AFP in HCC Management 1. **Diagnosis:** AFP >400 ng/mL + imaging findings (APHE) = diagnostic for HCC without biopsy 2. **Prognostication:** Predicts recurrence risk and guides adjuvant therapy decisions 3. **Surveillance:** Serial AFP monitoring post-resection detects early recurrence 4. **Treatment Response:** Decline in AFP after treatment indicates good response **Clinical Pearl:** In this patient, the elevated AFP (1200 ng/mL) indicates aggressive tumor biology and high recurrence risk, but resection is still justified if hepatic reserve is adequate. Adjuvant sorafenib or other systemic therapy may be considered post-resection based on risk factors. **Warning:** ~~AFP >400 ng/mL is an absolute contraindication to surgery~~ — this is incorrect. AFP level guides prognostication and adjuvant therapy decisions, not surgical eligibility. Surgical candidacy depends on liver function, tumor size/number, and performance status. ### Specificity and Sensitivity of AFP **Key Point:** AFP is NOT specific for HCC alone: - Elevated in benign conditions: cirrhosis, chronic hepatitis B/C, pregnancy - Elevated in other malignancies: germ cell tumors, gastric cancer, pancreatic cancer - Sensitivity for HCC diagnosis: ~60–70% (lower in small tumors) This is why imaging confirmation (APHE on CT/MRI) is required for diagnosis, not AFP alone. [cite:Robbins 10e Ch 19]